One Capital Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

One Capital Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,537	Closed	-$254K	–	533
2025 Q3	$254K	Sell	6,537 -6,562	-50%	-$238K	0.01%	442
2025 Q2	$442K	Sell	13,099 -82,012	-86%	-$2.6M	0.02%	375
2025 Q1	$3.02M	Sell	95,111 -84,843	-47%	-$3.22M	0.1%	144
2024 Q4	$6.99M	Sell	179,954 -2,532	-1%	-$106K	0.23%	98
2024 Q3	$8.21M	Buy	182,486 +12,408	+7%	+$555K	0.26%	97
2024 Q2	$7.1M	Buy	170,078 +30,835	+22%	+$1.29M	0.24%	94
2024 Q1	$6.34M	Buy	139,243 +12,656	+10%	+$576K	0.23%	97
2023 Q4	$5.85M	Sell	126,587 -8,483	-6%	-$346K	0.23%	100
2023 Q3	$5.49M	Buy	135,070 +5,973	+5%	+$272K	0.24%	97
2023 Q2	$6.26M	Buy	129,097 +13,294	+11%	+$665K	0.28%	88
2023 Q1	$5.71M	Buy	115,803 +4,334	+4%	+$223K	0.28%	97
2022 Q4	$5.64M	Buy	111,469 +7,694	+7%	+$397K	0.3%	93
2022 Q3	$5.21M	Buy	103,775 +605	+0.6%	+$34.1K	0.31%	86
2022 Q2	$5.04M	Buy	103,170 +13,947	+16%	+$707K	0.3%	86
2022 Q1	$5.36M	Buy	+89,223	New	+$5.63M	0.28%	93

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

One Capital Management's GNOM Position: Q4 2025 in Review

One Capital Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2025, closing a stake of 6,537 shares — an estimated $254K sold.

One Capital Management first reported a position in GNOM in Q1 2022 and held it in 15 quarters. The position peaked at $8.21M in Q3 2024. 40 funds tracked by Wall St. Rank hold GNOM as of Q4 2025.

One Capital Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
One Capital Management sold 6,537 Global X Genomics & Biotechnology ETF shares in Q4 2025, an estimated $254K.
One Capital Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and held it in 15 quarters.
One Capital Management's Global X Genomics & Biotechnology ETF position peaked at $8.21M in Q3 2024.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2025.

Based on One Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.